Erratum: Stylopine: a potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy.
MG-63
VEGFR2
benzylisoquinoline alkaloids
osteosarcoma
stylopine
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2023
2023
Historique:
received:
27
04
2023
accepted:
27
04
2023
medline:
22
5
2023
pubmed:
22
5
2023
entrez:
22
5
2023
Statut:
epublish
Résumé
[This corrects the article DOI: 10.3389/fphar.2023.1150270.].
Identifiants
pubmed: 37214468
doi: 10.3389/fphar.2023.1213155
pii: 1213155
pmc: PMC10196444
doi:
Types de publication
Published Erratum
Langues
eng
Pagination
1213155Commentaires et corrections
Type : ErratumFor
Informations de copyright
Copyright © 2023 and Frontiers Production Office.